Pentagon Eyes Search for Virus-Fighting Protein ‘Cocktails’

Diane Barnes
See more stories about...
Diane Barnes
Oct. 4, 2013, 10:02 a.m.

WASH­ING­TON — The U.S. De­fense De­part­ment is weigh­ing a new search for im­mune-pro­tein “cock­tails” it hopes will pro­tect hu­mans against Ebola and oth­er deadly, weapon-us­able vir­uses.

The Pentagon two weeks ago in­vited sci­ent­ists to sub­mit re­search pro­pos­als for design­ing “mono­clonal an­ti­bod­ies” that could pro­tect against Ebola and Mar­burg, as well as “al­phavir­uses” such as Venezuelan equine en­ceph­al­it­is.

Pentagon plan­ners have been turn­ing to an­ti­bod­ies as a pos­sible tool be­cause “no easy and quick fix” for such agents has emerged from ef­forts to de­vel­op vac­cines or tra­di­tion­al an­ti­vir­al treat­ments, said Gigi Gron­vall, a seni­or as­so­ci­ate with the Cen­ter for Health Se­cur­ity at the Uni­versity of Pitt­s­burgh Med­ic­al Cen­ter.

The early-stage re­search now un­der con­sid­er­a­tion ideally would lead to single-shot treat­ments cap­able of guard­ing troops for months from mul­tiple vir­us types, the De­fense Threat Re­duc­tion Agency said in a Sept. 18 so­li­cit­a­tion. DTRA of­fi­cials wel­comed re­search­ers to pro­pose “‘cock­tails’ that may en­able cross-pro­tec­tion against mul­tiple spe­cies of vir­us.”

The em­phas­is on “cock­tails” makes the latest DTRA pro­pos­al par­tic­u­larly not­able, be­cause sev­er­al stud­ies sug­gest that mixes of sev­er­al an­ti­bod­ies can be par­tic­u­larly ef­fect­ive in fight­ing patho­gens, Gron­vall told Glob­al Se­cur­ity News­wire in a tele­phone in­ter­view. An­ti­bod­ies hit their tar­gets with such spe­cificity that a treat­ment with mul­tiple im­mune pro­teins can help ac­count for slight vari­ations between in­vad­ing mi­crobes.

Mono­clonal an­ti­bod­ies have been in use since the 1980s to treat can­cer and im­mune-linked ail­ments such as rheum­at­oid arth­rit­is, but their use against in­fec­tious patho­gens has lagged, ac­cord­ing to a DTRA-sponsored re­port co-au­thored by Gron­vall on the tech­no­logy’s biode­fense po­ten­tial.

The United States last year li­censed the first in­hal­a­tion an­thrax treat­ment to use the tech­no­logy, which in­volves cre­at­ing massive quant­it­ies of a single im­mune “an­ti­body.” The hu­man body nat­ur­ally gen­er­ates such pro­teins, each of which is de­signed to mark a spe­cif­ic patho­gen or tox­in for elim­in­a­tion by oth­er im­mune-sys­tem com­pon­ents.

One an­ti­body cock­tail grown in mod­i­fied to­bacco plants showed prom­ising po­tency against Ebola in­fec­tions spe­cific­ally, ac­cord­ing to a study pub­lished in Au­gust.

“There have been a lot of changes in the way that mono­clonal an­ti­body tech­no­lo­gies have evolved over the last sev­er­al years, and it makes mono­clonal an­ti­bod­ies a very nice piece of their ap­proach to med­ic­al coun­ter­meas­ures,”  Gron­vall said.

The latest DTRA Broad Agency An­nounce­ment seeks pro­pos­als for stud­ies no longer than one year, with a cost no great­er than $500 mil­lion. The fil­ing dead­line is Oct. 16.

What We're Following See More »
ANOTHER MEETING WITH PRIEBUS
Trump to Meet with Ryan, Leadership Next Week
6 minutes ago
THE LATEST

A day after saying he could not yet support Donald Trump's presidential bid, House Speaker Paul Ryan has invited the billionaire to a meeting in Washington next week with House leadership. Ryan and Republican National Committee Chairman Reince Priebus will also meet separately with Trump. 

Source:
‘EXACTING STANDARDS’
Obama on Trump: ‘This Is a Really Serious Job’
24 minutes ago
THE DETAILS

"President Obama used the White House podium on Friday to dismiss Donald Trump as an unserious candidate to succeed him, and said leading the country isn't a job that's suited to reality show antics." At a briefing with reporters, the president said, "I just want to emphasize the degree to which we are in serious times and this is a really serious job. This is not entertainment. This is not a reality show. This is a contest for the presidency of the United States. And what that means is that every candidate, every nominee needs to be subject to exacting standards and genuine scrutiny."

Source:
MORE EXECUTIVE ORDERS
Panama Papers Spur White House to Crack Down on Evasion
2 hours ago
THE DETAILS

In the The White House on Thursday night unveiled a series of executive actions to combat money laundering—"among the most comprehensive response yet to the Panama Papers revelations." The president's orders will tighten transparency rules, close loopholes that allow "foreigners to hide financial activity behind anonymous entities in the U.S., and demand stricter “customer due diligence” rules for banks.

Source:
THE QUESTION
Who’s #NeverTrump Courting as Possible Candidates
2 hours ago
THE ANSWER

The #NeverTrump movement is now mulling the idea of recruiting a candidate to run as an independent or under a third-party banner. But who might it be? The Hill offers a preliminary list.

  • Sen. Ben Sasse (R-NE)
  • Mitt Romney
  • 2012 (and perhaps 2016) Libertarian candidate Gary Johnson
  • Former Marine Gen. John Kelly
  • Rep. Justin Amash (R-MI)
  • Former Sen. Tom Coburn (R-OK)
  • South Carolina Gov. Nikki Haley
  • Sen. Rand Paul (R-KY)
Source:
362,000 JOBS ADDED
‘Mildly Disappointing’ Jobs Report
3 hours ago
THE DETAILS

The U.S. economy added 160,000 jobs in April, a "mildly disappointing" result relative to the 200,000 expected, according to the New York Times' Neil Irwin. On the plus side, hourly earnings were up 2.5% from a year ago. But on the other hand, "the labor force shrank by 362,000 people and the labor force participation rate fell by 0.2 percentage points."

Source:
×